• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Cell Rep . Hybrid immunity-based induction of durable pan-endemic-coronavirus immunity in the elderly

tetano

Editor, Senior Moderator
Cell Rep


. 2025 Feb 16;44(2):115314.
doi: 10.1016/j.celrep.2025.115314. Online ahead of print. Hybrid immunity-based induction of durable pan-endemic-coronavirus immunity in the elderly

Lucie Loyal[SUP] 1 [/SUP], Julian Braun[SUP] 1 [/SUP], Ulf Reimer[SUP] 2 [/SUP], Lil Meyer-Arndt[SUP] 3 [/SUP], Larissa Henze[SUP] 1 [/SUP], Beate Kruse[SUP] 1 [/SUP], Manuela Dingeldey[SUP] 1 [/SUP], Maike Mangold[SUP] 1 [/SUP], Janina Behrens[SUP] 1 [/SUP], Pinkus Tober Lau[SUP] 4 [/SUP], Janine Michel[SUP] 5 [/SUP], Marica Grossegesse[SUP] 5 [/SUP], Karsten Schnatbaum[SUP] 2 [/SUP], Holger Wenschuh[SUP] 2 [/SUP], Wibke Johannis[SUP] 6 [/SUP], Veronica Di Cristanziano[SUP] 7 [/SUP], Andreas Nitsche[SUP] 5 [/SUP], Florian Klein[SUP] 7 [/SUP], Leif-Erik Sander[SUP] 8 [/SUP], Andreas Thiel[SUP] 9 [/SUP]



Affiliations
Abstract

Repeated vaccinations and infections have led to diverse states of hybrid immunity against SARS-CoV-2 in the global population. However, age and comorbidities can compromise protection against severe disease, and antibody-mediated immunity is undercut by viral immune escape mutations. Whether and to what extent durable T cell responses compensate for reduced humoral immunity, particularly in the elderly, have not been investigated. Here, we utilize SARS-CoV-2-specific and pan-coronavirus-derived peptide pools, including or excluding spike glycoprotein-derived epitopes, to measure vaccination and infection induced pan-human endemic coronavirus (PHEC)-directed T cell immunity. In contrast to vaccinated individuals, hybrid immunity induced by vaccination and SARS-CoV-2 infection comprises high frequencies of PHEC-reactive T cells with comparable frequencies and functional TCR avidities across all age groups. With waning humoral immunity and vulnerability to escape mutations, PHEC-reactive T cells may provide critical protection. Our findings underscore the importance of incorporating pan-coronavirus T cell epitopes in future vaccine strategies.

Keywords: CP: Immunology; SARS-CoV-2; T cell responses; aging; antibody titers; avidity; cross-reactivity; endemic coronaviruses; epitopes; hybrid immunity; polyfunctionality.

 
Back
Top Bottom